Donald
Well-Known Member
- Relationship to Diabetes
- Type 2
Sir Andrew Witty, chief executive of GlaxoSmithKline, announced a "strategic review" of iconic brands Lucozade and Ribena as group sales slipped 1pc over the year.
http://click.email.telegraph.co.uk/...1a4442ecde91c32cb1e8a2dc973ad0d82802765c2ee8f
http://click.email.telegraph.co.uk/...1a4442ecde91c32cb1e8a2dc973ad0d82802765c2ee8f